MASSIRONI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 1.639
EU - Europa 1.365
AS - Asia 922
SA - Sud America 80
AF - Africa 9
OC - Oceania 4
Totale 4.019
Nazione #
US - Stati Uniti d'America 1.618
RU - Federazione Russa 350
IT - Italia 333
SG - Singapore 324
HK - Hong Kong 322
DE - Germania 205
IE - Irlanda 179
CN - Cina 145
SE - Svezia 132
BR - Brasile 73
GB - Regno Unito 35
ID - Indonesia 30
KR - Corea 30
FR - Francia 29
FI - Finlandia 20
AT - Austria 17
UA - Ucraina 16
CA - Canada 15
IN - India 13
NL - Olanda 13
PH - Filippine 12
BE - Belgio 8
PL - Polonia 7
VN - Vietnam 7
CZ - Repubblica Ceca 5
TW - Taiwan 5
AU - Australia 4
MM - Myanmar 4
MX - Messico 4
MY - Malesia 4
TR - Turchia 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
EC - Ecuador 3
EG - Egitto 3
PK - Pakistan 3
BG - Bulgaria 2
DK - Danimarca 2
IL - Israele 2
KG - Kirghizistan 2
MA - Marocco 2
SA - Arabia Saudita 2
ZA - Sudafrica 2
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BJ - Benin 1
CO - Colombia 1
DZ - Algeria 1
ES - Italia 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
JP - Giappone 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
TJ - Tagikistan 1
VE - Venezuela 1
Totale 4.019
Città #
Ann Arbor 510
Hong Kong 322
Singapore 255
Dublin 173
Frankfurt am Main 146
Chandler 118
Milan 106
Ashburn 71
Fairfield 67
Wilmington 62
Santa Clara 54
New York 53
Shanghai 51
Moscow 42
Princeton 41
Houston 33
Woodbridge 32
Jakarta 29
Los Angeles 27
Chicago 26
Seattle 24
London 23
Cambridge 22
Seoul 22
Beijing 21
Hefei 21
Lawrence 20
Florence 19
Altamura 17
San Diego 17
Munich 16
Rome 16
Hangzhou 14
Nuremberg 13
Bari 11
Helsinki 11
Guangzhou 10
Davao City 8
Boardman 7
Desio 7
Garbagnate Milanese 7
Seo-gu 7
São Paulo 7
Toronto 7
Vienna 7
Falls Church 6
Pune 6
Brno 5
Comazzo 5
Dearborn 5
Dong Ket 5
Düsseldorf 5
Romola 5
Turku 5
Andover 4
Antwerp 4
Bologna 4
Butuan 4
Dallas 4
Fremont 4
Genoa 4
Jinan 4
Monza 4
Rio de Janeiro 4
Tashkent 4
Wroclaw 4
Antibes 3
Belo Horizonte 3
Bergamo 3
Brussels 3
Cinisello Balsamo 3
Council Bluffs 3
Hyderabad 3
Jacksonville 3
Kilburn 3
Kuala Lumpur 3
Lappeenranta 3
Lauterbourg 3
Modena 3
Naples 3
New Taipei 3
Roubaix 3
Sydney 3
Vicenza 3
Vigevano 3
Warsaw 3
Arese 2
Atlanta 2
Bellinzago Novarese 2
Bonndorf 2
Brasília 2
Brooklyn 2
Bushey 2
Cairo 2
Casatenovo 2
Changsha 2
Charlotte 2
Dubai 2
Esslingen am Neckar 2
Federal Way 2
Totale 2.755
Nome #
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 230
New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma 224
The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective 219
Understanding short bowel syndrome: Current status and future perspectives 208
Endoscopic Findings in Patients Infected With 2019 Novel Coronavirus in Lombardy, Italy 199
High rates of 30-day mortality in patients with cirrhosis and COVID-19 194
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 180
Intratumor Microbiome in Neuroendocrine Neoplasms: A New Partner of Tumor Microenvironment? A Pilot Study 161
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy 154
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 154
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 106
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 105
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 104
Somatostatin analogs in patients with Zollinger Ellison syndrome (ZES): an observational study 103
Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies 95
Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive Review 85
Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management 83
Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future 82
Incidence and prevalence of gastric neuroendocrine tumors in patients with chronic atrophic autoimmune gastritis 81
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study 81
Clinical challenge for gastroenterologists–Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review 77
Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms 77
Distinguishing features of autoimmune gastritis depending on previous H. pylori infection or positivity to anti-parietal cell antibodies: Results from the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO) 76
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 75
Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies? 74
Exploring the spectrum of incidental gastric polyps in autoimmune gastritis 72
Eosinophilic esophagitis: does age matter? 68
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 66
Use of IBD Drugs in Patients with Hepatobiliary Comorbidities: Tips and Tricks 65
COVID-19 in patients with neuroendocrine neoplasms: two-year results of the INTENSIVE study 63
Paradoxical association between dyspepsia and autoimmune chronic atrophic gastritis: Insights into mechanisms, pathophysiology, and treatment options 62
Sporadic and MEN1-related gastrinoma and Zollinger–Ellison syndrome: differences in clinical characteristics and survival outcomes 58
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 58
Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: A systematic review and meta-analysis 57
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 57
Systematic review-Pancreatic involvement in inflammatory bowel disease 56
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: Interim analysis of prospective ASPEN trial 53
Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence? 52
Ultrasound muscle assessment for sarcopenia detection in inflammatory bowel disease: A prospective study 51
Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial 47
Beyond the gluten-free diet: Innovations in celiac disease therapeutics 43
Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance 42
Totale 4.197
Categoria #
all - tutte 20.512
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.512


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 0 0 0 0 0 5
2020/2021568 26 8 45 34 67 70 63 70 47 47 44 47
2021/2022411 38 43 55 28 41 28 3 22 28 24 22 79
2022/2023594 65 148 54 57 59 63 19 34 42 12 19 22
2023/2024673 18 11 17 85 62 151 120 33 58 17 13 88
2024/20251.816 90 164 157 77 148 99 137 57 152 334 207 194
Totale 4.197